Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Indian Science
  4. Volume 1, Issue 1
  5. Article
Volume 1, Issue 1
  • ISSN: 2210-299X
  • E-ISSN: 2210-3007
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

Abstract

Background

Traditional approach to shelf-life prediction claims a substantial amount of product development time, leading to significant delays.

Objective

The capability of the unconventional Accelerated Stability Assessment Program (ASAP) to decode chemical stability and expedite shelf-life prediction is discussed in the manuscript.

Methods

As per the ASAP approach, shelf-life limiting attributes for two APIs’ and a formulation were identified based on the isoconversion ratio. Isoconversion times at varying accelerated conditions were obtained and the degradation kinetics were modeled using the humidity-modified Arrhenius equation. R2 and Q2 values were derived to assure model predictability. Temperature and humidity sensitivity of the attributes were determined from the activation energy; Ea, and humidity sensitivity factor, B, respectively. Degradation plots demonstrated the dynamics of degradation with time. The predicted values were verified by the available real-time data.

Results

The degradation rate was modeled for impurities that exhibited conversion substantiated by an isoconversion ratio between 0.25-2.0. The Ea and B data provided valuable details regarding the sensitivity of the products. Predicted shelf-life of less than a year for the finished product instigated redevelopment. In the case of the APIs’, the existing storage conditions were found unsuitable for shelf-life stability, and alternate conducive conditions were identified.

Conclusion

The study provided cognizance regarding the distinct degradation pattern of an API and its formulation and the contradictory storage requirement for APIs’ of two different molecules. While the traditional approach claims 3-6 months to predict shelf-life, the ASAP approach provides the same with enhanced accuracy in just 3-4 weeks.

© 2023 The Author(s). Published by Bentham Science Publisher.
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cis/10.2174/012210299X258686231026051150
2023-01-01
2025-01-27

  • From This Site

    /content/journals/cis/10.2174/012210299X258686231026051150
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cis/1/1/CIS-1-E2210299X258686.html?itemId=/content/journals/cis/10.2174/012210299X258686231026051150&mimeType=html&fmt=ahah

References

  1. SureshP. BasuP.K. Improving pharmaceutical product development and manufacturing: Impact on cost of drug development and cost of goods sold of pharmaceuticals.J. Pharm. Innov.20083317518710.1007/s12247‑008‑9043‑1
     [Google Scholar]
  2. Stability testing of new drug substances and products, ICH Q1A (R2), Ver. 04https://database.ich.org/sites/default/files/Q1A%28R2%29%20Guideline.pdf2003
  3. YangM. ByrnS.R. ClaseK.L. An analytic investigation of the drug formulation-based recalls in the usa: See more beyond the literal.AAPS PharmSciTech202021519810.1208/s12249‑020‑01726‑932676955
     [Google Scholar]
  4. KerstiensE.A. ByrnS.R. ClaseK.L. The identification of quality risk factors for non-biological complex drugs and epilepsy drugs using statistical analysis of formulation-based recalls in the USA.AAPS PharmSciTech20222311910.1208/s12249‑021‑02165‑w34904204
     [Google Scholar]
  5. LiQ.C. QiuF. CohenK. TougasT. LiJ. McCaffreyJ. PurdueT. SongJ.J. SwanekF. AbelairaS. Best practices for drug substance stress and stability studies during early-stage development part I—conducting drug substance solid stress to support phase Ia clinical trials.J. Pharm. Innov.201273-421422410.1007/s12247‑012‑9136‑8
     [Google Scholar]
  6. ClancyD. HodnettN. OrrR. OwenM. PetersonJ. Kinetic model development for accelerated stability studies.AAPS PharmSciTech20171841158117610.1208/s12249‑016‑0565‑427422651
     [Google Scholar]
  7. OlivaA. LlabrésM. FariñaJ.B. Data analysis of kinetic modelling used in drug stability studies: Isothermal versus nonisothermal assays.Pharm. Res.200623112595260210.1007/s11095‑006‑9096‑016969699
     [Google Scholar]
  8. CampaC. PronceT. PaludiM. WeustenJ. ConwayL. SaveryJ. RichardsC. ClénetD. Use of stability modeling to support accelerated vaccine development and supply.Vaccines.2021910111410.3390/vaccines910111434696222
     [Google Scholar]
  9. EversA. ClénetD. Pfeiffer-MarekS. Long-term stability prediction for developability assessment of biopharmaceutics using advanced kinetic modeling.Pharmaceutics202214237510.3390/pharmaceutics1402037535214107
     [Google Scholar]
  10. FuM. PerlmanM. LuQ. VargaC. Pharmaceutical solid-state kinetic stability investigation by using moisture-modified Arrhenius equation and JMP statistical software.J. Pharm. Biomed. Anal.201510737037710.1016/j.jpba.2015.01.01425656488
     [Google Scholar]
  11. RodanteF. VecchioS. TomassettiM. Kinetic analysis of thermal decomposition for penicillin sodium salts.J. Pharm. Biomed. Anal.20022961031104310.1016/S0731‑7085(02)00144‑912110388
     [Google Scholar]
  12. VyazovkinS. WightC.A. Kinetics in solids.Annu. Rev. Phys. Chem.199748112514910.1146/annurev.physchem.48.1.12515012442
     [Google Scholar]
  13. ScrivensG. ClancyD. GerstP. Theory and Fundamentals of Accelerated Predictive Stability (APS) Studies, Accelerated Predictive Stability (APS) studies.NetherlandsElsevier2018337310.1016/B978‑0‑12‑802786‑8.00003‑6
     [Google Scholar]
  14. WatermanK.C. CarellaA.J. GumkowskiM.J. LukulayP. MacDonaldB.C. RoyM.C. ShamblinS.L. Improved protocol and data analysis for accelerated shelf-life estimation of solid dosage forms.Pharm. Res.200724478079010.1007/s11095‑006‑9201‑417372701
     [Google Scholar]
  15. WatermanK.C. The application of the Accelerated Stability Assessment Program (ASAP) to quality by design (QbD) for drug product stability.AAPS PharmSciTech201112393293710.1208/s12249‑011‑9657‑321748541
     [Google Scholar]
  16. WatermanK.C. SwansonJ.T. LippoldB.L. A scientific and statistical analysis of accelerated aging for pharmaceuticals. Part 1: accuracy of fitting methods.J. Pharm. Sci.2014103103000300610.1002/jps.2407525043838
     [Google Scholar]
  17. WilliamsH.E. BrightJ. RoddyE. PoultonA. CosgroveS.D. TurnerF. HarrisonP. BrookesA. MacDougallE. AbbottA. GordonC. A comparison of drug substance predicted chemical stability with ICH compliant stability studies.Drug Dev. Ind. Pharm.20180362904510.1080/03639045.2018.154270730395722
     [Google Scholar]
  18. BlessyM. PatelR.D. PrajapatiP.N. AgrawalY.K. Development of forced degradation and stability indicating studies of drugs—A review.J. Pharm. Anal.20144315916510.1016/j.jpha.2013.09.00329403878
     [Google Scholar]
  19. SnapeT.J. AstlesA. DaviesJ. Understanding the chemical basis of drug stability and degradation.Pharm. J.20101710.1211/PJ.2021.1.7642
     [Google Scholar]
  20. GreenspanL. Humidity fixed points of binary saturated aqueous solutions.J. Res. Natl. Bur. Stand., A Phys. Chem.197781A1899610.6028/jres.081A.011
     [Google Scholar]
  21. MalcolmL. Accelerated Stability Assessment Program (ASAP) Applications in a Postapproval Environment.Accelerated Predictive Stability Fundamentals and Pharmaceutical Industry Practices201828730410.1016/B978‑0‑12‑802786‑8.00012‑7
     [Google Scholar]
  22. GentonD. KesselringU.W. Effect of temperature and relative humidity on nitrazepam stability in solid state.J. Pharm. Sci.197766567668010.1002/jps.2600660517874750
     [Google Scholar]
  23. ŠimonP. Isoconversional methods.J. Therm. Anal. Calorim.200476112313210.1023/B:JTAN.0000027811.80036.6c
     [Google Scholar]
  24. TolT. TawdeH. GoradS. JagdaleA. KulkarniA. KasbaleA. DesaiA. SamantaG. Optimization of a liquid chromatography method for the analysis of related substances in daclatasvir tablets using design of experiments integrated with the steepest ascent method and Monte Carlo simulation.J. Pharm. Biomed. Anal.202017811294310.1016/j.jpba.2019.11294331677954
     [Google Scholar]
  25. BenstockD. CeglaF. Extreme value analysis (EVA) of inspection data and its uncertainties.NDT Int.201787687710.1016/j.ndteint.2017.01.008
     [Google Scholar]
  26. Humidity control in refrigeration systems.Available from: http://plumbingandhvac.ca/humidity-control-in-refrigeration-systems/ (Accessed on: 18 May 2022).
/content/journals/cis/10.2174/012210299X258686231026051150
Loading
Early Prediction of the Chemical Stability of Drug Substances and Drug Products during the Development Phase
Curr. Indian Sci. 1, E2210299X258686 (2023); https://doi.org/10.2174/012210299X258686231026051150
/content/journals/cis/10.2174/012210299X258686231026051150
/content/journals/cis/10.2174/012210299X258686231026051150
Loading

Data & Media loading...

Supplements

Supplementary data associated with this article has been submitted along with this manuscript.

file format download Download

  • Article Type:     Research Article
Keyword(s): Accelerated stability assessment program; Arrhenius equation; Chemical stability; Development phase; Iso-conversion; Shelf-life prediction

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test